Key facts
- This page summarizes Christopher Bunka's Form 4 filing for Lexaria Bioscience Corp. (LEXX).
- 1 reported transaction and 6 derivative rows are listed below.
- Accepted by SEC: 30 Oct 2023, 12:30.
Christopher Bunka - 26 Oct 2023 Form 4 Insider Report for Lexaria Bioscience Corp. (LEXX)
- Reporting relationship
- Chief Executive Officer, Director
- Issuer ticker
- LEXX
- Reported as of
- 26 Oct 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 30 Oct 2023, 12:30:47 UTC
- Prior SEC filing
- 18 Oct 2022
- Next SEC filing
- 10 May 2024
- Source filing
- View source filing
- Reporting owner signature
- /Chris Bunka/
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Christopher Bunka filed Form 4 for Lexaria Bioscience Corp. (LEXX) on 30 Oct 2023.
Change
- Previous filing in this sequence was filed on 18 Oct 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
LEXX
holding
common shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 273,543
- Date
- 26 Oct 2023
- Ownership
- Direct
LEXX
holding
common shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 254,412
- Date
- 26 Oct 2023
- Ownership
- Private Holding Company
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
LEXX
transaction
Derivative
Stock Options
Award
- Transaction value
- $0
- Shares
- +30,000
- Change %
- +30%
- Price
- $0.000000
- Shares after
- 131,001
- Date
- 26 Oct 2023
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 30,000
- Exercise price
- $1.15
LEXX
holding
Derivative
Warrants
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 6,667
- Date
- 26 Oct 2023
- Ownership
- Private Holding Company
- Underlying class
- Common Shares
- Underlying amount
- 6,667
- Exercise price
- $10.50
LEXX
holding
Derivative
Stock Options
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 32,667
- Date
- 26 Oct 2023
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 26,000
- Exercise price
- $3.00
- Footnotes
- F1
LEXX
holding
Derivative
Stock Options
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 56,001
- Date
- 26 Oct 2023
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 23,334
- Exercise price
- $3.00
- Footnotes
- F2
LEXX
holding
Derivative
Stock Options
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 71,001
- Date
- 26 Oct 2023
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 15,000
- Exercise price
- $3.00
- Footnotes
- F3
LEXX
holding
Derivative
Stock Options
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 101,001
- Date
- 26 Oct 2023
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 30,000
- Exercise price
- $2.91
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Repriced from $5.83 pursuant to shareholder approval received on May 9, 2023
Footnote F2
Repriced from $7.08 pursuant to shareholder approval received on May 9, 2023
Footnote F3
Repriced from $6.23 pursuant to shareholder approval received May 9, 2023